Jun Peng

3.2k total citations
103 papers, 2.5k citations indexed

About

Jun Peng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Jun Peng has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 26 papers in Cardiology and Cardiovascular Medicine and 17 papers in Oncology. Recurrent topics in Jun Peng's work include Cardiac Fibrosis and Remodeling (12 papers), Cell death mechanisms and regulation (11 papers) and RNA Interference and Gene Delivery (9 papers). Jun Peng is often cited by papers focused on Cardiac Fibrosis and Remodeling (12 papers), Cell death mechanisms and regulation (11 papers) and RNA Interference and Gene Delivery (9 papers). Jun Peng collaborates with scholars based in China, United States and Canada. Jun Peng's co-authors include Arthur S. Alberts, Hui Lou, Bradley J. Wallar, Jialing Lin, Pamela J. Swiatek, Xiaoming Zheng, Ping Chen, Jiumao Lin, Jianfeng Chu and Suzanne M. Lapolla and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jun Peng

99 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Peng China 27 1.1k 395 359 256 222 103 2.5k
Ik‐Soon Jang South Korea 31 1.6k 1.4× 368 0.9× 245 0.7× 280 1.1× 345 1.6× 114 3.0k
Peng Zhao China 33 1.5k 1.4× 302 0.8× 535 1.5× 339 1.3× 467 2.1× 97 3.4k
Fei Li China 29 1.0k 0.9× 180 0.5× 179 0.5× 360 1.4× 220 1.0× 112 2.4k
Shengpeng Wang China 24 1.2k 1.1× 404 1.0× 232 0.6× 137 0.5× 202 0.9× 57 2.7k
Xiumei Zhang China 33 1.3k 1.2× 169 0.4× 126 0.4× 223 0.9× 270 1.2× 124 3.0k
Min Young Kim South Korea 35 1.8k 1.6× 182 0.5× 357 1.0× 397 1.6× 300 1.4× 167 3.7k
Jarosław Czyż Poland 32 2.0k 1.8× 167 0.4× 432 1.2× 264 1.0× 192 0.9× 111 3.9k
Da‐Woon Jung South Korea 26 1.3k 1.1× 300 0.8× 177 0.5× 341 1.3× 256 1.2× 125 2.4k
Dong Han China 28 1.2k 1.1× 124 0.3× 239 0.7× 143 0.6× 218 1.0× 66 2.5k

Countries citing papers authored by Jun Peng

Since Specialization
Citations

This map shows the geographic impact of Jun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Peng more than expected).

Fields of papers citing papers by Jun Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Peng. The network helps show where Jun Peng may publish in the future.

Co-authorship network of co-authors of Jun Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Peng. A scholar is included among the top collaborators of Jun Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Peng. Jun Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Meizhu, Lingqi Chen, Hong Chen, et al.. (2025). Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study. European Journal of Pharmacology. 994. 177393–177393. 1 indexed citations
2.
Peng, Jun, et al.. (2024). Regulation of seed germination: ROS, epigenetic, and hormonal aspects. Journal of Advanced Research. 71. 107–125. 22 indexed citations
3.
4.
Cheng, Ying, Guosheng Lin, Jing Lin, et al.. (2024). Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approach. European Journal of Pharmacology. 981. 176876–176876. 3 indexed citations
5.
Shen, Aling, Meizhu Wu, Farman Ali, et al.. (2023). Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation. Scientific Reports. 13(1). 12140–12140. 7 indexed citations
6.
Wo, Da, Jingxiao Chen, Xiaohui Zhou, et al.. (2023). Inhibition of a novel Dickkopf-1-LDL receptor–related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. European Heart Journal. 45(9). 688–703. 8 indexed citations
7.
Chen, Daxin, Shan Lin, Huajian Gao, et al.. (2022). Qingda granule alleviate angiotensin ⅱ-induced hypertensive renal injury by suppressing oxidative stress and inflammation through NOX1 and NF-κB pathways. Biomedicine & Pharmacotherapy. 153. 113407–113407. 10 indexed citations
8.
9.
Gao, Qian, E. Ma, Jingxiao Chen, et al.. (2022). Qingda granule prevents obesity-induced hypertension and cardiac dysfunction by inhibiting adverse Akt signaling activation. Heliyon. 8(12). e12099–e12099. 5 indexed citations
10.
11.
Cheng, Ying, Jianfeng Chu, Meizhu Wu, et al.. (2021). Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway. Biomedicine & Pharmacotherapy. 143. 112124–112124. 26 indexed citations
12.
Shen, Zhiqing, Xiangyan Wu, Jianfeng Chu, et al.. (2020). Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-β1/Smad2/3 pathways. Biomedicine & Pharmacotherapy. 130. 110618–110618. 18 indexed citations
13.
Cao, Zhiyun, Jinyan Zhao, Jun Peng, et al.. (2019). Babao Dan induces gastric cancer cell apoptosis via regulating MAPK and NF-κB signaling pathways. Journal of International Medical Research. 47(10). 5106–5119. 18 indexed citations
14.
He, Fei, Jianfeng Chu, Hongwei Chen, et al.. (2019). Qingxuan Jiangya Decoction (清眩降压汤) Prevents Blood Pressure Elevation and Ameliorates Vascular Structural Remodeling via Modulating TGF-β 1/Smad Pathway in Spontaneously Hypertensive Rats. Chinese Journal of Integrative Medicine. 26(3). 180–187. 14 indexed citations
15.
Chen, Hongwei, Aling Shen, Liya Liu, Jun Peng, & Jianfeng Chu. (2019). Bear Bile Powder Inhibits Growth of Hepatocellular Carcinoma via Suppressing STAT3 Signaling Pathway in Mice. Chinese Journal of Integrative Medicine. 26(5). 370–374. 9 indexed citations
16.
17.
Hu, Haixia, Zuanfang Li, Xiaoqin Zhu, et al.. (2013). GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway. International Journal of Molecular Medicine. 32(6). 1281–1286. 20 indexed citations
18.
Zheng, Haiyin, Wei Xu, Jiumao Lin, Jun Peng, & Zhenfeng Hong. (2013). Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis. Molecular Medicine Reports. 7(3). 848–854. 19 indexed citations
19.
Peng, Jun, Feng He, Zhi Zhang, et al.. (2010). Amphipathic Tail-anchoring Peptide and Bcl-2 Homology Domain-3 (BH3) Peptides from Bcl-2 Family Proteins Induce Apoptosis through Different Mechanisms. Journal of Biological Chemistry. 286(11). 9038–9048. 28 indexed citations
20.
Colucci‐Guyon, Emma, Florence Niedergang, Bradley J. Wallar, et al.. (2005). A Role for Mammalian Diaphanous-Related Formins in Complement Receptor (CR3)-Mediated Phagocytosis in Macrophages. Current Biology. 15(22). 2007–2012. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ik‐Soon Jang Breakdown of academic impact, for papers by Peng Zhao Breakdown of academic impact, for papers by Fei Li Breakdown of academic impact, for papers by Shengpeng Wang Breakdown of academic impact, for papers by Xiumei Zhang Breakdown of academic impact, for papers by Min Young Kim Breakdown of academic impact, for papers by Jarosław Czyż Breakdown of academic impact, for papers by Da‐Woon Jung Breakdown of academic impact, for papers by Dong Han
Rankless by CCL
2026